NCT07365995 2026-01-26
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3 Not yet recruiting
BioNTech SE
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Instituto do Cancer do Estado de São Paulo
Fudan University
Medical University of Vienna
Dokuz Eylul University
University of Bern